Cargando…
Niacin analogue, 6-Aminonicotinamide, a novel inhibitor of hepatitis B virus replication and HBsAg production
Background: Hepatitis B surface antigen (HBsAg) is one of the important clinical indexes for hepatitis B virus (HBV) infection diagnosis and sustained seroconversion of HBsAg is an indicator for functional cure. However, the level of HBsAg could not be reduced by interferons and nucleoside analogs e...
Autores principales: | Ren, Fang, Yang, Xiao, Hu, Zhong-Wen, Wong, Vincent Kam Wai, Xu, Hong-Yan, Ren, Ji-Hua, Zhong, Shan, Jia, Xiao-Jiong, Jiang, Hui, Hu, Jie-Li, Cai, Xue-Fei, Zhang, Wen-Lu, Yao, Fang-Long, Yu, Hai-Bo, Cheng, Sheng-Tao, Zhou, Hong-Zhong, Huang, Ai-Long, Law, Betty Yuen Kwan, Chen, Juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945246/ https://www.ncbi.nlm.nih.gov/pubmed/31680002 http://dx.doi.org/10.1016/j.ebiom.2019.10.022 |
Ejemplares similares
-
Performance Evaluation of an Improved HBsAg Assay (HBsAg NEXT) for the Detection of HBsAg Levels
por: Gupta, Ekta, et al.
Publicado: (2023) -
Prediction for HBsAg seroconversion in children with chronic hepatitis B
por: Zhong, Yan-Wei, et al.
Publicado: (2021) -
Pre-transplant donor HBV DNA+ and male recipient are independent risk factors for treatment failure in HBsAg+ donors to HBsAg- kidney transplant recipients
por: Wang, Xian-ding, et al.
Publicado: (2021) -
Clinical cure rate of inactive HBsAg carriers with HBsAg <200 IU/ml treated with pegylated interferon
por: Li, Hong, et al.
Publicado: (2022) -
Circulating immune complexes and mutations of HBsAg are associated with the undetectable HBsAg in anti-HBs and HBeAg positive occult hepatitis B virus infection
por: Yan, Ying, et al.
Publicado: (2022)